Clinical Trial Update: Research Study Investigating How Well NDec Works in People With Sickle Cell Disease [Phase 2]

View source ↗

Summary

This document notes the completion of a Phase 2 clinical trial evaluating NDec in people with sickle cell disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sickle Cell Disease

Drugs mentioned

• NDec

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Sickle Cell Disease | Phase 2 | Status: COMPLETED